PacBio Stock Up on HiFi Sequencing Adoption for Major SUDC Research

Key Takeaways HiFi sequencing is adopted as a first-line approach in a major SUDC study sequencing 200 family trios.PACB shares rose 10.8% after reporting preliminary 2025 revenue of $160M, with Q4 revenue of $44.6M.PACB's Revio with SPRQ-Nx aims to boost throughput, data quality and lower costs for complex genetic cases.Pacific Biosciences of California, Inc. (PACB) , popularly known as PacBio, recently announced that its HiFi whole-genome sequencing technology has been adopted as a first-line approach in ...